0001209191-23-027374.txt : 20230504 0001209191-23-027374.hdr.sgml : 20230504 20230504165148 ACCESSION NUMBER: 0001209191-23-027374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230502 FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanna Bastiano CENTRAL INDEX KEY: 0001829069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23889674 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001829069 Sanna Bastiano C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Cell & Genetic Therapies 1 Common Stock 2023-05-02 4 S 0 1411 350.32 D 38302 D Common Stock 2023-05-02 4 S 0 42 351.65 D 38260 D Common Stock 2023-05-02 4 S 0 169 353.24 D 38091 D Common Stock 2023-05-03 4 S 0 2053 350.44 D 36038 D Common Stock 2023-05-03 4 S 0 728 351.60 D 35310 D Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1, which was entered into on 08/10/2022. Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $350.32 (range $350.00 to $350.92). Open market sales reported on this line occurred at a weighted average price of $351.65 (range $351.48 to $351.80). Open market sales reported on this line occurred at a weighted average price of $353.24 (range $353.21 to $353.49). Open market sales reported on this line occurred at a weighted average price of $350.44 (range $350.00 to $350.94). Open market sales reported on this line occurred at a weighted average price of $351.60 (range $351.01 to $352.00). /s/ Christiana Stevenson, Attorney-in-Fact 2023-05-04